R 715
CAS No. 185052-09-9
R 715( ——— )
Catalog No. M40637 CAS No. 185052-09-9
R715 is a selective bradykinin B1 receptor antagonist. R715 significantly attenuates the hyperalgesic effect developed in Streptozotocin -diabetic mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameR 715
-
NoteResearch use only, not for human use.
-
Brief DescriptionR715 is a selective bradykinin B1 receptor antagonist. R715 significantly attenuates the hyperalgesic effect developed in Streptozotocin -diabetic mice.
-
DescriptionR715 is a selective bradykinin B1 receptor antagonist. R715 significantly attenuates the hyperalgesic effect developed in Streptozotocin -diabetic mice.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number185052-09-9
-
Formula Weight1140.33
-
Molecular FormulaC57H81N13O12
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (87.69 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gabra BH, et al. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides. 2003;24(8):1131-1139.?
molnova catalog
related products
-
Cyanidin-3-O-[6-O-tr...
Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-trans-caffeyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside
-
N-(4-bromo-2-chlorop...
N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide is a chemical compound.
-
Phlorizin
Phlorizin is a non-selective SGLT inhibitor found in apple, for hSGLT1( Ki=300 nM) and hSGLT2( Ki=39 nM) .
Cart
sales@molnova.com